top of page
The Campbell Lab

The aim of the Campbell lab is the characterisation of chemokines and chemokine receptor expression in cells clinically to better advise their use applications such as cell therapy and organ transplantation.

Postdocs

Chris Kelly

About Chris 

I am a Postdoctoral Research Associate working in the CRG. I actually did my PhD with the CRG, investigating the phenomenon of signalling bias observed with several chemokine receptors, which I completed in 2019. Since then, I’ve worked on several projects, both within the CRG and other lab groups. Most of these have focused on better understanding mesenchymal stromal cells (MSCs) and their potential utilisation as a cell therapy. My most recent work in this area was on the development of GMP-compatible methods for the generation of olfactory mucosa MSCs (as a precursor to their potential use in clinical trials of treatments for demyelinating conditions in the central nervous system), which was recently published. I rejoined the CRG in 2023, undertaking a project in which we hope to exploit our expertise in chemokine biology and cellular migration to develop better cell therapies for the treatment of cancer.

 

Additionally, I have been a committee member of the Network for Early Career Researcher Development on and off for a few years now, have been involved in several public engagement events (including acting as city co-ordinator for Glasgow for the nationwide public engagement event, Pint of Science), and do some teaching on the Immunology honours degree programme here at the university.

​

​

​

Contact: Christopher.Kelly@glasgow.ac.uk

Ph.D. Students

Rachel Cooper

About Rachel 

I am a research associate at Tissues, Cells & Advanced Therapeutics within the Scottish National Blood Transfusion Service. I work on development of T cell therapies to treat severe viral infections, with my main interest in Epstein-Barr virus (EBV) related diseases. I’m in my final year of a part-time PhD collaborating with CRG to extensively profile our clinically efficacious EBV T cell therapy for post-transplant lymphoma, and investigate how these cells migrate and function once infused into the patient. In my free time I enjoy swimming, climbing, and love to go exploring. 

​

​

​

Contact: 2514390c@student.gla.ac.uk

bottom of page